These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1780684)

  • 1. Serum levels of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological diseases.
    Torre GC; Rembado R; Barbetti V; Vigliercio GP; Foglia M; Calabrese A; Corongiu F
    Scand J Clin Lab Invest Suppl; 1991; 207():15-8. PubMed ID: 1780684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumor-associated trypsin inhibitor (TATI) in women with benign and malignant gynecological disease.
    Inaudi P; Petrilli S; De Leo V; Bernabei A; Pasqui L; D'Antona N
    Scand J Clin Lab Invest Suppl; 1991; 207():11-3. PubMed ID: 1780683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease.
    Loizate Toricaguena A; Lamiquiz Vallejo A; Dominguez Merru-Urrutia MJ; Legorburu Escudero JF
    Scand J Clin Lab Invest Suppl; 1991; 207():59-62. PubMed ID: 1780694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.
    Medl M; Ogris E; Peters-Engl C; Leodolter S
    Br J Cancer; 1995 May; 71(5):1051-4. PubMed ID: 7734298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated trypsin inhibitor (TATI) in bone diseases.
    Rapellino M; Pecchio F; Broggi S; Baldi C; Ricardi G; Libertucci D
    Scand J Clin Lab Invest Suppl; 1991; 207():65-6. PubMed ID: 1780696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases.
    Piantino P; Arosaio E
    Scand J Clin Lab Invest Suppl; 1991; 207():67-9. PubMed ID: 1780697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated trypsin inhibitor (TATI) in the diagnosis of lung cancer.
    Pecchio F; Rapellino M; Baldi S; Casali V; Libertucci D; Coni F
    Scand J Clin Lab Invest Suppl; 1991; 207():63-4. PubMed ID: 1780695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Rispoli G; Prontera C; Bianchi R; Fioretti P
    Scand J Clin Lab Invest Suppl; 1991; 207():19-24. PubMed ID: 1780685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology.
    Gadducci A; Ferdeghini M; Facchini V; Ceccarini T; Prontera C; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(2):111-5. PubMed ID: 2379509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
    Halila H; Lehtovirta P; Stenman UH
    Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-associated trypsin inhibitor and renal cell carcinoma.
    Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
    Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C; Medl M; Ogris E; Leodolter S
    Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis.
    Medl M; Ogris E; Peters-Engl C; Mierau M; Buxbaum P; Leodolter S
    Br J Obstet Gynaecol; 1997 Jan; 104(1):78-81. PubMed ID: 8988701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy.
    Huhtala ML; Kahanpää K; Seppälä M; Halila H; Stenman UH
    Int J Cancer; 1983 Jun; 31(6):711-4. PubMed ID: 6190763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Rapellino M; Pecchio F; Baldi S; Adamo MR; Macri M; Ricardi G
    Scand J Clin Lab Invest Suppl; 1991; 207():47-9. PubMed ID: 1780690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated trypsin inhibitor in pancreatic diseases.
    Aroasio E; Piantino P
    Scand J Clin Lab Invest Suppl; 1991; 207():71-3. PubMed ID: 1723534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum TATI levels and clinical correlation in tumors of the head and neck.
    Rayo JI; Garcia-Talavera JR; Martin M; Muñoz A; Del Cañizo A
    Scand J Clin Lab Invest Suppl; 1991; 207():33-5. PubMed ID: 1780687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Klockars M; Pettersson T; Fröseth B; Selroos O; Stenman UH
    Chest; 1990 Nov; 98(5):1159-64. PubMed ID: 2225961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.